18 June 2020
Oncode Oncology Bridge Fund appoints Investment Advisory Committee
The Oncode Oncology Bridge Fund provides early stage financing to support the creation and growth of new enterprises based on highly innovative science performed by researchers at the Oncode Institute. We are proud to announce that the Bridge Fund has appointed its Investment Advisory Committee (IAC). The role of the IAC is to review and make recommendations on investment proposals presented by the Fund Managers. Initially it consists of three members and will gradually expand to five members with diverse early-stage venture experience in the field of life sciences. The members of the committee have a mixture of technical, scientific, business, and investment experience in building and growing therapeutics, diagnostics and services focussed oncology companies.
Chris De Jonghe, Valorization Director at Oncode, says: “We are very pleased to welcome such skilled talent to our committee. Their knowledge and hands-on experience with the start-up environment will be a tremendous support for Oncode Investigators launching new ventures.”
Find out more about the Oncode Oncology Bridge Fund.